0.1100
0.0000
(0.00%)
At close: January 10 at 9:43:30 AM EST
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-4,481.3600
-3,043.4720
-2,289.1900
-3,938.9700
Investing Cash Flow
10,224.0510
-107.5490
-373.5450
-166.1120
Financing Cash Flow
-6,821.4910
3,102.8320
2,807.9020
4,278.8770
End Cash Position
-212.8210
1,104.9010
1,153.0900
1,007.9230
Capital Expenditure
-56.7410
-81.2320
-353.5450
-126.1120
Issuance of Capital Stock
0.5740
973.7040
--
695.4690
Issuance of Debt
--
2,777.1600
1,796.1920
2,394.8030
Repayment of Debt
-6,653.0320
-527.4370
-535.8510
-21.2710
Free Cash Flow
-4,538.1010
-3,124.7040
-2,642.7350
-4,065.0820
12/31/2020 - 10/1/2003
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ONCO.CN Onco-Innova
1.2000
0.00%
TVGNW Tevogen Bio Holdings Inc.
0.0750
-5.66%
APS.TO Aptose Biosciences Inc.
0.3150
+1.61%
HEM.V Hemostemix Inc.
0.2400
+20.00%
THTX Theratechnologies Inc.
1.8700
-6.27%
APTO Aptose Biosciences Inc.
0.2200
+3.19%
TH.TO Theratechnologies Inc.
2.6900
-7.88%
BSEM BioStem Technologies, Inc.
15.00
-3.16%
AUPH Aurinia Pharmaceuticals Inc.
8.07
-3.24%
VSTM Verastem, Inc.
5.73
-2.88%